Government Affairs
Refine Search
Pharmaceutical
Following more than two years of groundwork, the Hungarian government’s health department has decided about the inclusion of 29 new, innovative medicines and their indications into subsidy, affecting several therapeutic fields, providing the most effective treatment for the illnesses concerned, according to the latest issue of the Hungarian Official Journal. 19 October 2018
Pharmaceutical
Among the millions of perspectives for UK Prime Minister Theresa May to consider during Wednesday’s talks with European Union (EU) leaders over a Brexit deal is that of AstraZeneca, one of the largest UK drugmakers. 17 October 2018
Pharmaceutical
On Thursday, the US Department of Health and Human Services (HHS) announced that approximately $2.34 billion in Ryan White HIV/AIDS Program grants were awarded to cities, counties, states, and local community-based organizations in fiscal year 2018. 12 October 2018
Pharmaceutical
The Russian government plans to provide access to imported drugs that have not undergone clinical trials within Russia, according to recent statements by some senior officials of the Russian Ministry of Health. 10 October 2018
Pharmaceutical
A leading British clinical research organization (CRO), Richmond Pharmacology, has published a detailed report criticizing current UK immigration policy and supporting proposals to install a skills-based migration system after Brexit. 9 October 2018
Pharmaceutical
The pharmaceutical sector could be one of the worst affected by a no-deal Brexit, with interruptions to medicine imports and supply chain products putting at risk patients’ health in the short-term at least. 5 October 2018
Pharmaceutical
At Wednesday’s Plenary session, the European Parliament adopted the Report on the Commission Proposal for a Regulation on Health Technology Assessment (HTA). 4 October 2018
Pharmaceutical
The Russian watchdog the Federal Anti-Monopoly Service (FAS) suspects the Bristol-Myers Squibb (NYSE: BMY) had participated in a cartel agreement during the conduct of state tenders for the purchases of drugs for state needs last year, reports The Pharma Letter’s local correspondent. 3 October 2018
Generics
The pharmaceutical intellectual property aspects of the United States-Mexico-Canada Agreement (USMCA), which was agreed on Monday to replace the former North American Free Trade Agreement (NAFTA) accord, have come in for criticism from the Canadian Generic Pharmaceutical Association (CGPA). 2 October 2018
Pharmaceutical
At its annual meeting in Berlin, the European Association for the Study of Diabetes (EASD) has launched a new initiative, aimed at enabling “the sustainability of European healthcare systems to cope with the diabetes pandemic.” 2 October 2018
Pharmaceutical
The recently elected Morrison Australian government today said it will invest A$52 million ($38 million) to protect the nation’s teenagers against meningococcal disease, with the launch of a new free national program for 14 to 19 year olds. 25 September 2018
Pharmaceutical
China’s State Council, the executive body that oversees government operations, has listed a series of improvements that are needed for the selection and adoption of essential drugs. 21 September 2018
Pharmaceutical
The US Department of Health and Human Services (HHS) is spending big in a sign of how seriously it is taking the opioid epidemic. 20 September 2018
Biotechnology
Although Novartis’ CAR-T therapy Kymriah (tisagenlecleucel-T) was accepted onto the UK’s Cancer Drugs Fund (CDF) for children with a type of leukemia, adults with diffuse large B-cell lymphoma (DLBCL) have not yet been afforded the same treatment. 19 September 2018
Pharmaceutical
Latvia’s leading pharmaceutical trade group has issued a statement welcoming healthcare reforms in the country and strongly supporting their continuation. 19 September 2018
Pharmaceutical
The status of tuberculosis (TB) as the world’s leading killer among infectious diseases has been underlined by the Global Fund amid a report’s claim of a funding gap of $3.5 billion in 2018 alone in the fight to end its deadly impact. 19 September 2018
Generics
A proposal to fix a side effect of Europe’s Supplementary Protection Certificate (SPC) has taken a step closer to introduction. 18 September 2018
Pharmaceutical
The government of newly-inaugurated Australian Prime Minister Scott Morrison has announced it will invest A$48 million to list new treatments for lymphoma and multiple myeloma on the Pharmaceutical Benefits Scheme (PBS). 17 September 2018
Pharmaceutical
The Netherlands’ Medicines Evaluation Board (MEB) intends to intensify collaboration with its partner authority in Switzerland in the field of therapeutic product development and production. 17 September 2018
Pharmaceutical
US President Donald Trump’s recently initiated trade war with China has divided opinion between those who see it as a potentially industry-damaging misstep, and those who view the Chinese state as an aggressive opponent increasingly willing to rig the global trading system in its favor. 4 September 2018
Pharmaceutical
Efforts to combat antimicrobial resistance (AMR) are gaining momentum in Europe, with the introduction of innovative measures to drive the development of new antimicrobials. 25 November 2024
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze